纳米碳悬浊液在乳腺癌前哨淋巴结活检中的应用

Chinese Journal of Experimental Surgery(2015)

Cited 1|Views2
No score
Abstract
目的 探讨纳米碳悬浊液在乳腺癌前哨淋巴结活检(SLNB)中的应用.方法 对就诊的早期乳腺癌患者112例,随机对照入组,分别采用纳米碳悬浊液(A组,60例)和亚甲蓝+核素(B组,62例)作为SLNB的示踪剂,SLNB后随即行腋窝淋巴结清扫(ALND).采用两组率的非劣效性检验比较A组和B组的SLN检出率和假阴性率.结果 A组SLN检出率为96.70%,假阴性率为6.25%,B组SLN检出率为95.20%,假阴性率为0.两组SLNB检出率及假阴性率在非劣效性检验下,差异有统计学意义(P <0.025).结论 纳米碳悬浊液可作为新型的SLNB示踪剂,可以达到不亚于亚甲蓝与放射性核素联合示踪的效果.
More
Translated text
Key words
Breast neoplasms,Sentinel lymph node biospy,Nanogate carbon
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined